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Abstract 
Whether operative treatment for complex proximal humeral fractures (CPHFs) has a greater benefit over non-opera-
tive treatment remains controversial. There is no consensus on the optimal treatment in elderly patients with CPHFs. 
This updated meta-analysis of randomized controlled trials (RCTs) aims to investigate whether operative treatment 
is superior to non-operative treatment in CPHFs. The authors searched RCTs in the electronic databases (Cochrane 
Central Register of Controlled Trials, PubMed, EMBASE, Medline, Embase, Springer Link, Web of Knowledge, OVID and 
Google Scholar) from their establishment to July 2015. Researches on operative and non-operative treatment for 
CPHFs were selected in this meta-analysis. The quality of all studies was assessed and effective data was pooled for 
this meta-analysis. Outcome measurements were functional status include constant scores (CS scores) and disabilities 
of the arm, shoulder and hand scores (DASH scores), total complication rates and healthy-related quality of life. The 
meta-analysis was performed with software revman 5.3. Nine articles with a total 518 patients (average age 70.93) met 
inclusion criteria. Patients were followed up for at least 1 year in all the studies. No statistical differences were found 
between operative and non-operative treatment in CS scores at 12 mo (months) [MD 1.06 95 % CI (−3.51, 5.62)] and 
24 mo [MD −0.61 95 % CI (−5.87, 4.65)]. There are also no statistical differences between operative and non-operative 
treatment in DASH scores at 12 mo [MD −4.51 95 % CI (−13.49, 4.47)] and 24 mo [MD −7.43 95 % CI (−16.14, 1.27)]. 
Statistical differences were found between operative and non-operative treatment in total complication rates [RR 
1.55, 95 % CI (1.24, 1.94)]. Statistical differences in EQ-5D at 24 mo [MD 0.15, 95 % CI (0.05, 0.24)] were found between 
operative and non-operative treatment but no statistical differences were found in ED-5D at 12 mo [MD 0.08, 95 % CI 
(−0.01, 0.17)], 15D at 12 mo [MD 0.02, 95 % CI (−0.68, 0.73)] and 15D at 24 mo [MD 0.02, 95 % CI (−0.07, 0.83)]. Opera-
tive treatments did not significantly improve the functional outcome and healthy-related quality of life in elderly 
patients. Instead, Operative treatment for CPHFs led to higher incidence of postoperative complications.
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Background
Proximal humeral fractures are common injuries that 
comprises 5–6  % of all adult fractures, with the inci-
dence of 63.0/105 per year (Bengner et  al. 1988; Baron 
et al. 1996a, b). It is the third most common fracture after 
hip and wrist fractures that occur in patients older than 
60 years (Roux et al. 2012; Horak and Nilsson 1975; Kan-
nus et  al. 1996). The fractures are common in patients 
older than 60 years especially females. Nearly 85 % proxi-
mal humeral fractures are non- or minimally displaced 
and can be treated conservatively (Roux et  al. 2012). 
Many patients could regain shoulder function with non-
operative treatment (Yuksel et  al. 2011). The remaining 
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15 % displaced fractures which are challenge to surgeons 
can be treated with operative or non-operative treatment 
(Kim et al. 2012; Handoll and Ollivere 2010). These frac-
tures include 2-part fractures involving the surgical neck, 
3- and 4-part fractures which all have poor outcomes and 
the optimal treatment is still controversial. With recent 
advancement in technique and implants for fracture 
fixation (Russo et  al. 2013; Lill et  al. 2013; Vundelinckx 
et al. 2012), operative treatment has become increasingly 
popular for these injuries (Karataglis et al. 2011), includ-
ing internal fixation (Jost et al. 2013) and humeral head 
replacement (Cadet and Ahmad 2012), which increased 
treatment costs for this fracture. While non-operative 
treatment includes sling immobilization (Yuksel et  al. 
2011).
To date, meta-analysis comparing conservation with 
operative treatment for proximal humeral fractures have 
been available in recent years (Sun et al. 2015; Mao et al. 
2014; Jia et al. 2014; Fu et al. 2014; Li et al. 2013). How-
ever, they did not improve evidence-based decision mak-
ing because of lack of RCTs. Recently, several RCTs have 
investigated whether operative treatment may provide 
greater benefits than non-operative treatment (Rangan 
et al. 2015; Fjalestad and Hole 2014; Fjalestad et al. 2010, 
2012; Boons et al. 2012; Olerud et al. 2011a, b; Zyto et al. 
1997; Stableforth 1984). Whether operative treatment for 
CPHFs has a greater benefit over non-operative treat-
ment remains controversial. This updated meta-analysis 
of RCTs aims to investigate whether operative treatment 
is superior to non-operative treatment in CPHFs.
Methods
Search strategy
The authors conducted a search of the Cochrane Cen-
tral Register of Controlled Trials, PubMed, EMBASE, 
MEDLINE, Springer Link, Web of Knowledge, OVID 
and Google Scholar up to July 2015. No language restric-
tion was made. The search strategy first used Mesh terms 
[“Shoulder fractures” (Mesh) OR “Proximal Humerus 
fractures” (Mesh) OR “Proximal Humeral Fractures” 
(Mesh)] and type of clinical trial (randomized controlled 
trial) and then a secondary free search was performed 
using multiple keywords (humer* and fractur* and ran-
dom*) to ensure inclusion all possible studies. In addi-
tion, the reference lists of the included studies were 
checked for eligible studies.
Eligibility criteria
Studies were considered acceptable according to the fol-
lowing criteria: (1) complex displaced proximal humeral 
fractures; (2) operative treatment vs non-operative treat-
ment; (3) functional outcomes, complications or healthy-
related quality of life were described; and (4) randomized 
controlled trial study design. Studies were excluded if 
they (1) were abstracts, letters, or meeting proceedings; 
(2) had repeated data; or (3) enrolled patients with multi-
trauma or patients undergoing surgery for a revision, 
infection, or nonunion or malunion.
Data extraction
The eligible studies were reviewed and all appropriate 
data were extracted by two authors (LX, YC) indepen-
dently. The extracted data included general demographic 
characteristics, functional outcomes, complications and 
healthy-related quality of life.
Study quality assessment
The risk of bias of each study was independently assessed 
by two authors (FD, ZGZ), in accordance with the 
Cochrane risk of bias tool, which defines nine aspects: (1) 
random sequence generation (selection bias); (2) allocation 
concealment (selection bias); (3) blinding of participants 
(performance bias); (4) blinding of treatment provid-
ers (performance bias); (5) blinding of outcome assessors 
(detection bias); (6) intention to treat (attrition bias); (7) 
selective reporting (reporting bias); (8) comparable study 
groups; and (9) other bias. A qualification of risk of bias, 
including low risk, unclear risk, or high risk, was provided. 
The final qualification for each study was determined by 
consensus among three authors (LX, YC, and DMX).
Statistical analysis
Statistical analysis was performed with revman 5.3 soft-
ware (Cochrane Collaboration, Oxford, UK) for outcome 
measures. The outcomes were function outcome (CS 
scores; DASH scores; ASES; OSS and SF-12), complica-
tions (total complications rates; the rate of additional sur-
gery; infection; avascular necrosis; osteoarthritis; nerve 
injury; nonunion; impingement and re-displacement) 
and healthy-related quality of life (EQ-5D, 15D). Contin-
uous variables and dichotomous data were analyzed with 
mean difference (MD) and relative risk (RR), both with 
95 % confidence interval (CI), respectively. Statistical het-
erogeneity was assessed by the I2 statistics. Fixed-effects 
model was used when the heterogeneity was negligi-
ble (I2  <  50  %). Otherwise a random-effects model was 
adopted. To define sources of heterogeneity, subgroup 
analyses based on internal fixation and arthroplasty were 
defined during the analysis design phase. Publication bias 




Figure 1 illustrates the study flow. The initial search iden-
tified 190 references. After duplicate references were 
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removed and the titles, abstracts, and contents of the 
full text were examined, 9 articles included 7 RCTs were 
included in the meta-analysis (Rangan et  al. 2015; Fjal-
estad and Hole 2014; Fjalestad et  al. 2010, 2012; Boons 
et al. 2012; Olerud et al. 2011a, b; Zyto et al. 1997; Sta-
bleforth 1984). Table 1 shows the general characteristics 
of the 9 included articles. A total of 518 patients (average 
age 70.93) with CPHFs were included in this study. Mean 
age ranged from 65.6 to 79.9. The percentage of female 
patients ranged from 75 to 96  %. The studies followed 
patients for periods of 12–60 mo, and the rate of patient 
follow-up ranged from 72.5–98 %. 
Study quality
Figure 2 shows the quality of the RCTs as independently 
assessed by two authors (LX, YC). Six studies were sin-
gle-center studies and one study was multi-center study. 
five studies were judged as having used sufficient alloca-
tion concealment. Only one study used closed envelopes 
without reporting adequate safeguards. Only one study 
was reported to have blinded the outcome assessors. Six 
studies reported a proper intention-to-treat analysis and 
clearly stated interventions. The comparability of base-
line characteristics was generally acceptable.
Outcomes
Functional outcome
CS and DASH scores were the most commonly used to 
assess functional outcome of patients with displaced 
proximal humeral fractures. CS scores were mentioned 
in 6 studies and DASH scores were mentioned in two 
studies. No statistical differences were found between 
operative and non-operative treatment in CS scores at 12 
mo [MD 1.06 95 % CI (−3.51, 5.62)] (Fig. 3) and 24 mo 
[MD −0.61 95 % CI (−5.87, 4.65)] (Fig. 4), There are no 
statistical differences between operative and non-opera-
tive treatment in DASH scores at 12 mo [MD −4.51 95 % 
CI (−13.49, 4.47)] (Fig.  5) and 24 mo (MD −7.43 95  % 
CI (−16.14, 1.27)] (Fig.  6), Other functional outcomes 
(ASES, OSS and SF-12) have no statistical differences 
between operative and non-operative treatment either 
(Table 2).
Complications
Total complications rates [RR 1.55, 95  % CI (1.24, 
1.94)] have statistical differences between operative 
and non-operative treatment (Fig.  7). All the complica-
tion reported were summarized in Table  3. Six articles 
that included 497 patients provided data on the rate of 
additional surgery. The rate of additional surgery was 
significantly higher in the operative group compared 
with the non-operative group [RR 1.91, 95  % CI (1.06, 
3.45); Table  3]. No statistical differences were seen in 
the rates of infection; avascular necrosis; osteoarthritis; 
nerve injury; nonunion; impingement or re-displace-
ment between operative and non-operative treatment 
(Table 3).
Healthy‑related quality of life
Only the differences in EQ-5D at 24 mo [MD 0.15, 95 % 
CI (0.05, 0.24)] were found between operative and non-
operative treatment and no statistical differences were 
Fig. 1 Flow diagram of literature search
Table 1 Characteristics of included studies (O operative, N non-opreative)
Study Mean age (O/N) No. (O/N) % Female (O/N) Follow-up (mo) Rate of follow-up
Rangan et al. (2015) 67.42/66.12 114/117 77.6/76.0 24 86
Boons et al. (2012) 79.9/76.4 25/25 92/96 24 94
Fjalestad et al. (2010, 2012); Fjalestad and Hole (2014) 72.2/73.1 25/25 80/94 12 98.0
Olerud et al. (2011a, b) 72.9/74.9 30/30 80/83 24 88.3
Olerud et al. (2011a, b) 75.8/77.5 27/28 85/86 24 89.1
Stableforth (1984) 65.6/70.1 16/16 75/81.3 6–48 93.8
Zyto et al. (1997) 73/75 20/20 90/85 36–60 72.5
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found in ED-5D at 12 mo [MD 0.08, 95  % CI (−0.01, 
0.17)], 15D at 12 mo [MD 0.02, 95 % CI (−0.68, 0.73)] and 
15D at 24 mo [MD 0.02, 95 % CI (−0.07, 0.83)] (Table 4).
Sensitivity analysis
Due to the high heterogeneity in the above analysis, we 
performed subgroup analysis in the meta-analysis based 
on different surgical treatments. A sensitivity analysis 
was also conducted by removing one study at a time. We 
found that no article substantially influenced the results 
in this analysis.
Publication bias
The publication bias was evaluated by a funnel plot. The 
funnel plot shapes showed no obvious evidence of a sym-
metry. The results suggested that publication bias was 
not evident in this meta-analysis.
Discussion
According to the Neer classification (Neer 1970a, b), the 
decision regarding the treatment of proximal humeral 
fractures is dependent on whether the four anatomical 
segments of the proximal humeral (the humeral head, 
shaft, and greater and lesser tubercles) are fractured or 
displaced. In our paper, CPHFs mean proximal humeral 
fractures excluding non- or minimally displaced proxi-
mal humeral fractures. CPHFs have poor outcomes and 
the optimal treatment is still controversial. There are sev-
eral kinds of surgical methods for patients with CPHFs, 
including steosynthesis, hemiarthroplasty and reverse 
shoulder arthroplasty (Murray et al. 2011). Whether sur-
gical methods could help to resume the painless range 
of motion and good shoulder function, thereby allow 
for rapid return to work and previous level of activity is 
still unclear. We performed this updated meta-analysis 
concerning the comparison of operative and non-oper-
ative treatment for the CPHFs. This meta-analysis was 
based on 7 RCTs in 9 articles (Rangan et  al. 2015; Fjal-
estad and Hole 2014; Fjalestad et  al. 2010, 2012; Boons 
et al. 2012; Olerud et al. 2011a, b; Zyto et al. 1997; Sta-
bleforth 1984). In this study, we compared the efficiency 
and safety of surgical and conservative interventions for 
CPHFs in elderly patients. The results of this meta-anal-
ysis indicated that surgical intervention only improved 
the ED-5D at 24 mo but suffered more complications. 
Meanwhile, no statistical differences were observed in CS 
scores, DASH scores, ED-5D at 12 mo and 15D.
Fig. 2 Risk of bias summary. Abbreviations: +, low risk; ?, unclear risk; 
−, high risk
Fig. 3 Forest plot for constant scores at 12 mo
Page 5 of 9Xie et al. SpringerPlus  (2015) 4:728 
Function outcome was a major clinical evaluation in all 
studies. Various measures have been developed to assess 
shoulder and arm disability. The measures can contain 
either self-reported or performance-based assessments 
or a combination of both. Among all these measure, 
the CS score is a widely accepted functional score of 
shoulder joint in the world (Constant and Murley 1987; 
Conboy et  al. 1996; Rocourt et  al. 2008). No statistical 
difference was detected with respect to CS score in our 
meta-analysis. The DASH score is a measurement of 
upper-extremity disability and symptoms (Hudak et  al. 
1996). There was also no statistical difference with regard 
to DASH score between two groups in our findings. 
Other functional outcomes (ASES, OSS and SF-12) have 
Fig. 4 Forest plot for constant scores at 24 mo
Fig. 5 Forest plot for DASH scores at 12 mo
Fig. 6 Forest plot for DASH scores at 24 mo
Table 2 Functional status outcome (NA not available)
Outcome Studies No. of patients (O/N) MD (95 % CI) P for MD I2 P for heterogeneity
ASES score at 6 mo 1 23/25 0.10 (−3.66, 3.86) 0.96 NA NA
ASES score at 12 mo 1 23/25 −0.70 (−4.52, 3.12) 0.72 NA NA
OSS 1 114/117 0.75 (−1.45, 2.95) 0.50 NA NA
SF-12 physical component score 1 111/115 2.00 (−1.00, 5.00) 0.19 NA NA
SF-12 mental component score 1 111/115 −1.00 (−3.87, 1.87) 0.49 NA NA
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no statistical differences between operative and non-
operative treatment either. Based on these outcomes, our 
analysis shows that operative treatment has no significant 
benefit on shoulder and arm functional recovery com-
pared to non-operative treatment.
Total complications events in operative group were 
more common than that in conservative group especially 
the postoperative complications such as penetration of 
implant into joint rate, metalwork problem. For patients 
with operative treatment, the incidence of additional sur-
gery is higher. This higher incidence of additional surgery 
in operative group may be associated with surgical exper-
tise (Namdari et al. 2012). These complications could be 
minimized by improved operative techniques (Owsley 
and Gorczyca 2008; Egol et  al. 2008). All deaths men-
tioned in this article were unrelated with interventions, 
thus, no statistically differences were found between 
operative and non-operative treatment in mortality. 
Some of these complication (infection; avascular necro-
sis; osteoarthritis; nerve injury; nonunion; impingement 
or re-displacement) may occur in both operative and 
non-operative treatment, and no statistical differences 
were found between operative and non-operative treat-
ment in these complication.
Healthy-related quality of life in patients treated with 
operative treatment outperformed that with conservative 
treatments for EQ-5D at 24 mo, while no statistical dif-
ferences in ED-5D at 12 mo, 15D at 12 mo and 15D at 
24 mo (Table  4). While the number of studies included 
is limited. Only Olerud et  al. (2011a, b) reported that 
hemiarthroplasty can improve EQ-5D at 24 mo, so more 
well designed, high quality RCTs are needed. All of these 
results indicate that neither operative nor non-operative 
treatment can achieve ideal clinical results, and operative 
treatment might fail to show a clinical benefit compared 
with non-operative treatment.
Although this meta-analysis was performed with 
the best available evidence presently, some unavoid-
able weaknesses earned to be noted. First, although we 
used multiple search strategies and available databases 
to include all possible studies, publication bias may be 
unavoidable. Second, the number of studies included is 
small. More well designed, high quality RCTs are needed. 
Furthermore, the types of operative or non-operative 
treatment in studies were varied and the follow-up peri-
ods in studies ranged largely from 1 year to several years. 
In addition, the variety of outcome measures limits the 
authors’ ability to combine outcomes and make definitive 
conclusions.
Although some limitations were unavoidable, this study 
has some merits. First, the search style based on the com-
puter and manual search ensures a complete inclusion 
Fig. 7 Forest plot for total complications rates
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of relevant studies. Secondly, no significant heterogene-
ity was observed in most variables. Last, all the studies in 
this meta-analysis were RCTs.
Conclusion
For CPHFs, current limited studies suggest that operative 
treatments did not significantly improve the functional 
outcome and healthy-related quality of life. Instead, 
Operative treatment for CPHFs led to higher incidence of 
postoperative complications. Based on the results of this 
meta-analysis, both treatment can achieve a similar effect 
on CPHFs, but operative treatment may increase the rate 
of total complication. Large, definitive RCTs are needed. 
Fortunately, such RCTs have already been designed (Lau-
nonen et al. 2012; Den Hartog et al. 2010; Handoll et al. 
2009; Brorson et al. 2009).
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Table 3 Total complication reported
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Additional surgery rate Boons et al. (2012)
Fjalestad et al. (2012)
Olerud et al. (2011a, b)
Rangan et al. (2015)
Stableforth (1984)
248/249 1.91 (1.06, 3.45) 0.03 13 0.33
Mortality Boons et al. (2012)
Fjalestad et al. (2012)
Rangan et al. (2015)
Stableforth (1984)
191/191 2.07 (0.88, 4.83) 0.09 0 0.94
Infection Fjalestad et al. (2012)
Olerud et al. (2011a, b)
Rangan et al. (2015)
Zyto et al. (1997)
213/216 5.05 (0.90, 28.35) 0.07 0 1.00
Avascular necrosis Fjalestad et al. (2012)
Olerud et al. (2011a, b)
Rangan et al. (2015)
Zyto et al. (1997)
Boons et al. (2012)
252/253 0.82 (0.38, 1.77) 0.61 16 0.31
Osteoarthritis Fjalestad et al. (2010)
Zyto et al. (1997)
41/41 1.34 (0.37, 4.82) 0.66 13 0.28
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Impingement Olerud et al. (2011a)
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Redisplacement Fjalestad et al. (2012)
Olerud et al. (2011a)
Zyto et al. (1997)
38/40 0.53 (0.10, 2.78) 0.45 48 0.16
Table 4 Health-related quality of life
Outcome Study No. of patients (O/N) MD (95 % CI) P for MD I2 P for heterogeneity
EQ-5D at 12 mo Olerud et al. (2011a, b) 53/52 0.08 (−0.01, 0.17) 0.10 0 % 0.83
EQ-5D at 24 mo Olerud et al. (2011a, b) 51/51 0.15 (0.05, 0.24) 0.004 0 % 0.65
15D at 12 mo Fjalestad et al. (2012) 23/25 0.02 (−0.03, 0.07) 0.44 NA NA
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